Earkart completes USFDA registration eyes global hearing healthcare market
New Delhi, Nov 19 (PTI) Earkart has completed its US Food and Drug Administration (FDA) establishment registration and secured active
New Delhi, Nov 19 (PTI) Earkart has completed its US Food and Drug Administration (FDA) establishment registration and secured active
New Delhi, Nov 19 (PTI) Earkart has completed its US Food and Drug Administration (FDA) establishment registration and secured active
New Delhi, Nov 19 (PTI) Earkart has completed its US Food and Drug Administration (FDA) establishment registration and secured active medical device listings across four hearing aid categories, marking a step towards its international expansion.
The company's portfolio covers prescription, wireless prescription and wireless OTC (over-the-counter) hearing aids, according to a company statement.
It aims to offer its branded hearing aids to US consumers at affordable prices, the company added.
Earkart, a hearing healthcare technology company, plans to explore partnerships, distribution opportunities and market-entry strategies in the US, leveraging its indigenous product development and manufacturing capabilities.
The US hearing aids market is estimated to grow from USD 4.65 billion in 2026 to USD 9.57 billion by 2035 at an annual growth rate of 8.4 per cent, according to Emergen Research.
"Completing our US FDA establishment registration and securing active device listings across four hearing aid categories is an important milestone in Earkart's international growth journey," the company said.
(This story has not been edited by THE WEEK and is auto-generated from PTI)